Provided by Tiger Trade Technology Pte. Ltd.

Cardiol Therapeutics Inc

1.07
+0.04003.88%
Post-market: 1.06-0.0100-0.93%19:57 EST
Volume:282.73K
Turnover:292.51K
Market Cap:119.22M
PE:-3.54
High:1.07
Open:1.01
Low:1.01
Close:1.03
52wk High:1.59
52wk Low:0.7709
Shares:111.42M
Float Shares:108.00M
Volume Ratio:0.73
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3023
EPS(LYR):-0.3562
ROE:-347.98%
ROA:-148.83%
PB:17.04
PE(LYR):-3.00

Loading ...

Company Profile

Company Name:
Cardiol Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
18
Office Location:
2265 Upper Middle Road East,Suite 602,Oakville,Ontario,Canada
Zip Code:
L6H 0G5
Fax:
905 481 2394
Introduction:
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.